Trial Details
RECRUITINGBasic Information
| Clinical ID | c1565 |
|---|---|
| Identifier | NCT05770609 |
| Trial Title | A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Mild to Moderate Ulcerative Colitis |
| Interventions | DRUG: SPH3127 Tablets with Dose A|DRUG: SPH3127 Tablets with Dose B|DRUG: SPH3127 Tablets placebo |
Participant Information
| Sponsor | Shanghai Pharmaceuticals Holding Co., Ltd |
|---|---|
| City | Guangzhou |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-06-19 |
|---|---|
| Primary Completion Date | 2025-02-15 |
| Completion Date | 2025-02-15 |